retatrutide mechanism of action triple agonist glp-1 gip glucagon Beyond GLP-1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based protocols demand nutrition support alongside prescribing What Is Retatrutide? The Triple

Alternatives of GLP-1s Below are all of our articles for you to learn about GLP-1s

Follow us on X @FAIRHealth About FAIR Health FAIR Health is a national, independent nonprofit organization that qualifies as a public charity under section 501(c)(3) of the federal tax code

FDA has documented over 1000 adverse event reports linked to compounded versions of semaglutide and tirzepatide

Natural metabolic health support through turmeric and moringa is meaningful for prediabetes, blood sugar management, and general metabolic wellness

Strategies such as hydration, smaller meals, adjusting fiber intake based on symptoms, and avoiding high-fat foods can ease symptoms

Cleveland Clinic: Menopause Diet: What to Eat to Help Manage Symptoms UCLA Health: The Best Way to Work Out After Menopause AARP: Are Weight Loss Drugs Risky for Older Adults